Adage Capital Partners GP »

Summit Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2026-06-30 $29M 2.0M 14.57
2025-03-31 $10M 538k 19.29

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
ConocoPhillips (COP)

View all positions for Adage Capital Partners GP

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics